
### [MONDO:0019298](http://purl.obolibrary.org/obo/MONDO_0019298)
**Label:** rare urticaria

**Subclasses:** [MONDO:0015554](http://purl.obolibrary.org/obo/MONDO_0015554) (Typical urticaria pigmentosa), [MONDO:0010481](http://purl.obolibrary.org/obo/MONDO_0010481) (angioedema), [MONDO:0019315](http://purl.obolibrary.org/obo/MONDO_0019315) (diffuse cutaneous mastocytosis), [MONDO:0015556](http://purl.obolibrary.org/obo/MONDO_0015556) (nodular urticaria pigmentosa), [MONDO:0015555](http://purl.obolibrary.org/obo/MONDO_0015555) (plaque-form urticaria pigmentosa), [MONDO:0018304](http://purl.obolibrary.org/obo/MONDO_0018304) (Schnitzler syndrome), [MONDO:0019316](http://purl.obolibrary.org/obo/MONDO_0019316) (maculopapular cutaneous mastocytosis), [MONDO:0015054](http://purl.obolibrary.org/obo/MONDO_0015054) (hereditary angioedema type 2), [MONDO:0019314](http://purl.obolibrary.org/obo/MONDO_0019314) (cutaneous mastocytoma), [MONDO:0015055](http://purl.obolibrary.org/obo/MONDO_0015055) (acquired angioedema type 2), [MONDO:0015056](http://purl.obolibrary.org/obo/MONDO_0015056) (acquired angioedema type 1), [MONDO:0019576](http://purl.obolibrary.org/obo/MONDO_0019576) (telangiectasia macularis eruptiva perstans), [MONDO:0015057](http://purl.obolibrary.org/obo/MONDO_0015057) (Renin-angiotensin-aldosterone system-blocker-induced angioedema), [MONDO:0019013](http://purl.obolibrary.org/obo/MONDO_0019013) (non-histaminic angioedema), [MONDO:0015053](http://purl.obolibrary.org/obo/MONDO_0015053) (hereditary angioedema type 1), [MONDO:0007969](http://purl.obolibrary.org/obo/MONDO_0007969) (Melkersson-Rosenthal syndrome), [MONDO:0012526](http://purl.obolibrary.org/obo/MONDO_0012526) (hereditary angioedema type 3), [MONDO:0019623](http://purl.obolibrary.org/obo/MONDO_0019623) (hereditary angioedema), [MONDO:0019624](http://purl.obolibrary.org/obo/MONDO_0019624) (acquired angioedema), [MONDO:0017244](http://purl.obolibrary.org/obo/MONDO_0017244) (pseudoxanthomatous diffuse cutaneous mastocytosis), [MONDO:0015340](http://purl.obolibrary.org/obo/MONDO_0015340) (drug rash with eosinophilia and systemic symptoms), [MONDO:0017243](http://purl.obolibrary.org/obo/MONDO_0017243) (bullous diffuse cutaneous mastocytosis), [MONDO:0008353](http://purl.obolibrary.org/obo/MONDO_0008353) (Pruritic urticarial papules and plaques of pregnancy), [MONDO:0019023](http://purl.obolibrary.org/obo/MONDO_0019023) (cutaneous mastocytosis), [MONDO:0007117](http://purl.obolibrary.org/obo/MONDO_0007117) (angioedema, hereditary, type 1/2), [MONDO:0013766](http://purl.obolibrary.org/obo/MONDO_0013766) (familial cold autoinflammatory syndrome 3), 

**Mapped go classes:** [GO:0030193](http://purl.obolibrary.org/obo/GO_0030193) (regulation of blood coagulation), [GO:0034396](http://purl.obolibrary.org/obo/GO_0034396) (negative regulation of transcription from RNA polymerase II promoter in response to iron), [GO:0009395](http://purl.obolibrary.org/obo/GO_0009395) (phospholipid catabolic process), [GO:0000778](http://purl.obolibrary.org/obo/GO_0000778) (condensed nuclear chromosome kinetochore), [GO:0043069](http://purl.obolibrary.org/obo/GO_0043069) (negative regulation of programmed cell death), [GO:0042730](http://purl.obolibrary.org/obo/GO_0042730) (fibrinolysis), [GO:0000775](http://purl.obolibrary.org/obo/GO_0000775) (chromosome, centromeric region), [GO:0001784](http://purl.obolibrary.org/obo/GO_0001784) (phosphotyrosine residue binding), [GO:0002316](http://purl.obolibrary.org/obo/GO_0002316) (follicular B cell differentiation), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001869](http://purl.obolibrary.org/obo/GO_0001869) (negative regulation of complement activation, lectin pathway), [GO:0034501](http://purl.obolibrary.org/obo/GO_0034501) (protein localization to kinetochore), [GO:0070006](http://purl.obolibrary.org/obo/GO_0070006) (metalloaminopeptidase activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0051209](http://purl.obolibrary.org/obo/GO_0051209) (release of sequestered calcium ion into cytosol), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0002092](http://purl.obolibrary.org/obo/GO_0002092) (positive regulation of receptor internalization), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0032958](http://purl.obolibrary.org/obo/GO_0032958) (inositol phosphate biosynthetic process), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0032959](http://purl.obolibrary.org/obo/GO_0032959) (inositol trisphosphate biosynthetic process), [GO:0004629](http://purl.obolibrary.org/obo/GO_0004629) (phospholipase C activity), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0031225](http://purl.obolibrary.org/obo/GO_0031225) (anchored component of membrane), [GO:0032237](http://purl.obolibrary.org/obo/GO_0032237) (activation of store-operated calcium channel activity), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0006661](http://purl.obolibrary.org/obo/GO_0006661) (phosphatidylinositol biosynthetic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0001402](http://purl.obolibrary.org/obo/GO_0001402) (signal transduction involved in filamentous growth), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0007599](http://purl.obolibrary.org/obo/GO_0007599) (hemostasis), [GO:0004435](http://purl.obolibrary.org/obo/GO_0004435) (phosphatidylinositol phospholipase C activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0001848](http://purl.obolibrary.org/obo/GO_0001848) (complement binding), [GO:0032026](http://purl.obolibrary.org/obo/GO_0032026) (response to magnesium ion), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway), [GO:0050853](http://purl.obolibrary.org/obo/GO_0050853) (B cell receptor signaling pathway), [GO:0045916](http://purl.obolibrary.org/obo/GO_0045916) (negative regulation of complement activation), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0033198](http://purl.obolibrary.org/obo/GO_0033198) (response to ATP), [GO:0004177](http://purl.obolibrary.org/obo/GO_0004177) (aminopeptidase activity), [GO:0007204](http://purl.obolibrary.org/obo/GO_0007204) (positive regulation of cytosolic calcium ion concentration), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 53.12%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 53.12%
- Thing 52.56%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 38.48%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005378](http://purl.obolibrary.org/obo/GO_0005378) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005377](http://purl.obolibrary.org/obo/GO_0005377) (obsolete intracellular copper ion transporter) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005376](http://purl.obolibrary.org/obo/GO_0005376) (obsolete plasma membrane copper transporter) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005373](http://purl.obolibrary.org/obo/GO_0005373) (obsolete heavy metal ion porter activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005370](http://purl.obolibrary.org/obo/GO_0005370) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005361](http://purl.obolibrary.org/obo/GO_0005361) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005349](http://purl.obolibrary.org/obo/GO_0005349) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005348](http://purl.obolibrary.org/obo/GO_0005348) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005341](http://purl.obolibrary.org/obo/GO_0005341) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005339](http://purl.obolibrary.org/obo/GO_0005339) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.48%


